Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keefer

Showing results (921-930 of 1,129) with videos related to

Pageof 113
Sort By:
Health Physics|November 25, 2003
An in situ gamma-ray spectrometry intercomparisonP Shebell, S Faller, M Monetti, et al.
AIDS Research and Human Retroviruses|December 1, 1994
Studies of high doses of a human immunodeficiency virus type 1 recombinant glycoprotein 160 candidate vaccine in HIV type 1-seronegative humans. The AIDS Vaccine Clinical Trials NetworkM C Keefer, B S Graham, R B Belshe, et al.
Vaccine|December 6, 2006
Effect of promoter strength on protein expression and immunogenicity of an HSV-1 amplicon vector encoding HIV-1 GagKathlyn Santos, Cindy M P Duke, Sol M Rodriguez-Colon, et al.
Free Radical Biology & Medicine|January 25, 2011
Effect of nitric oxide on neointimal hyperplasia based on sex and hormone statusMelissa E Hogg, Vinit N Varu, Ashley K Vavra, et al.
Chemical Research in Toxicology|May 1, 1989
Decomposition and quality control considerations in biological work with fecapentaene preparationsA J Streeter, P J Donovan, T Anjo, et al.
Plos One|February 22, 2017
Pre-existing neutralizing antibody mitigates B cell dysregulation and enhances the Env-specific antibody response in SHIV-infected rhesus macaquesJuan Pablo Jaworski, Peter Bryk, Zachary Brower, et al.
Journal of Medicinal Chemistry|July 11, 2006
Antitumor activity of JS-K [O2-(2,4-dinitrophenyl) 1-[(4-ethoxycarbonyl)piperazin-1-yl]diazen-1-ium-1,2-diolate] and related O2-aryl diazeniumdiolates in vitro and in vivoPaul J Shami, Joseph E Saavedra, Challice L Bonifant, et al.
The Journal of Infectious Diseases|October 1, 1994
Determinants of antibody response after recombinant gp160 boosting in vaccinia-naive volunteers primed with gp160-recombinant vaccinia virus. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Clinical Trials NetworkB S Graham, G J Gorse, D H Schwartz, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 5, 2014
Assay reproducibility and interindividual variation for 15 serum estrogens and estrogen metabolites measured by liquid chromatography-tandem mass spectrometryBarbara J Fuhrman, Xia Xu, Roni T Falk, et al.
Plos One|May 25, 2012
α-Thalassemia impairs the cytoadherence of Plasmodium falciparum-infected erythrocytesMichael A Krause, Seidina A S Diakite, Tatiana M Lopera-Mesa, et al.
Pageof 113

Showing results (921-930 of 1,129) with videos related to

Sort By:
Pageof 113
Health Physics|November 25, 2003
An in situ gamma-ray spectrometry intercomparisonP Shebell, S Faller, M Monetti, et al.
AIDS Research and Human Retroviruses|December 1, 1994
Studies of high doses of a human immunodeficiency virus type 1 recombinant glycoprotein 160 candidate vaccine in HIV type 1-seronegative humans. The AIDS Vaccine Clinical Trials NetworkM C Keefer, B S Graham, R B Belshe, et al.
Vaccine|December 6, 2006
Effect of promoter strength on protein expression and immunogenicity of an HSV-1 amplicon vector encoding HIV-1 GagKathlyn Santos, Cindy M P Duke, Sol M Rodriguez-Colon, et al.
Free Radical Biology & Medicine|January 25, 2011
Effect of nitric oxide on neointimal hyperplasia based on sex and hormone statusMelissa E Hogg, Vinit N Varu, Ashley K Vavra, et al.
Chemical Research in Toxicology|May 1, 1989
Decomposition and quality control considerations in biological work with fecapentaene preparationsA J Streeter, P J Donovan, T Anjo, et al.
Plos One|February 22, 2017
Pre-existing neutralizing antibody mitigates B cell dysregulation and enhances the Env-specific antibody response in SHIV-infected rhesus macaquesJuan Pablo Jaworski, Peter Bryk, Zachary Brower, et al.
Journal of Medicinal Chemistry|July 11, 2006
Antitumor activity of JS-K [O2-(2,4-dinitrophenyl) 1-[(4-ethoxycarbonyl)piperazin-1-yl]diazen-1-ium-1,2-diolate] and related O2-aryl diazeniumdiolates in vitro and in vivoPaul J Shami, Joseph E Saavedra, Challice L Bonifant, et al.
The Journal of Infectious Diseases|October 1, 1994
Determinants of antibody response after recombinant gp160 boosting in vaccinia-naive volunteers primed with gp160-recombinant vaccinia virus. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Clinical Trials NetworkB S Graham, G J Gorse, D H Schwartz, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 5, 2014
Assay reproducibility and interindividual variation for 15 serum estrogens and estrogen metabolites measured by liquid chromatography-tandem mass spectrometryBarbara J Fuhrman, Xia Xu, Roni T Falk, et al.
Plos One|May 25, 2012
α-Thalassemia impairs the cytoadherence of Plasmodium falciparum-infected erythrocytesMichael A Krause, Seidina A S Diakite, Tatiana M Lopera-Mesa, et al.
Pageof 113